MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

Search

Inspire Medical Systems Inc

Fermé

SecteurSoins de santé

94.29 2.61

Résumé

Variation du prix de l'action

24h

Actuel

Min

89.12

Max

95.55

Chiffres clés

By Trading Economics

Revenu

14M

9.9M

Ventes

7.4M

225M

P/E

Moyenne du Secteur

63.171

89.037

Marge bénéficiaire

4.424

Employés

1,246

EBITDA

16M

17M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+58.69% upside

Dividendes

By Dow Jones

Prochains Résultats

11 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

548M

2.7B

Ouverture précédente

91.68

Clôture précédente

94.29

Sentiment de l'Actualité

By Acuity

43%

57%

126 / 361 Classement par Healthcare

Inspire Medical Systems Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

20 janv. 2026, 23:43 UTC

Market Talk

Gold Consolidates; May Face Technical Correction -- Market Talk

20 janv. 2026, 23:42 UTC

Market Talk

Nikkei May Fall Amid Concerns Over U.S.-Europe Trade Relations -- Market Talk

20 janv. 2026, 23:41 UTC

Résultats

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- 2nd Update

20 janv. 2026, 23:29 UTC

Market Talk

RBA Rate Hike in February Would Be a Painful One -- Market Talk

20 janv. 2026, 23:26 UTC

Market Talk

Global Equities Roundup: Market Talk

20 janv. 2026, 23:26 UTC

Market Talk

James Hardie Appeals More as Reece's U.S. Strategy Comes Under Scrutiny -- Market Talk

20 janv. 2026, 22:45 UTC

Acquisitions, Fusions, Rachats

ACCC: Ampol-EG Deal Is First Assessment Subject to Phase 2 Review Under New Merger Control Regime

20 janv. 2026, 22:45 UTC

Acquisitions, Fusions, Rachats

ACCC Seeks Submissions in Response to Phase 2 Notice by February 4

20 janv. 2026, 22:44 UTC

Acquisitions, Fusions, Rachats

ACCC: Ampol's Offer to Sell 19 Retail Fuel Sites Doesn't Adequately Address Issues

20 janv. 2026, 22:44 UTC

Acquisitions, Fusions, Rachats

ACCC Identifies 115 EG Sites Where Deal Could Substantially Lessen Competition

20 janv. 2026, 22:43 UTC

Acquisitions, Fusions, Rachats

ACCC Says Deal Could Substantially Lessen Competition in Retail Supply of Petrol, Diesel in Several Markets in Australia

20 janv. 2026, 22:43 UTC

Acquisitions, Fusions, Rachats

Ampol's Acquisition of EG Australia to Undergo In-Depth Review by Competition Regulator

20 janv. 2026, 22:27 UTC

Acquisitions, Fusions, Rachats

Netflix Plans to Roll Out New Mobile User Interface Later This Year, Co-CEO Says

20 janv. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

Netflix Co-CEO Sees Uptick in Engagement for TV-Based Games

20 janv. 2026, 22:21 UTC

Acquisitions, Fusions, Rachats

Netflix Would Keep 45-Day Theater Release Window for Warner Bros. Films, Co-CEO Says

20 janv. 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Netflix Excited to Strengthen Warner Bros.'s Theatrical-Distribution Business, Co-CEO Says

20 janv. 2026, 22:19 UTC

Acquisitions, Fusions, Rachats

Netflix Pleased With Early Results for Podcasts, Co-CEO Says

20 janv. 2026, 22:18 UTC

Résultats

Netflix Stock Is Falling. This Is Overshadowing the Streamer's Earnings Beat. -- Barrons.com

20 janv. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Netflix's Live Events Are Boosting Retention, Co-CEO Says

20 janv. 2026, 22:16 UTC

Acquisitions, Fusions, Rachats

Netflix Remains 'Very Excited' About Live-Events Offering, Co-CEO Says

20 janv. 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Netflix's Proposed Deal for Warner Bros. Would Protect, Create Jobs, Co-CEO Says

20 janv. 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Netflix Competes for Attention Across Streaming, Broadcast, Cable, Gaming, Social Media, Video Platforms, Co-CEO Says

20 janv. 2026, 22:13 UTC

Acquisitions, Fusions, Rachats

Netflix Co-CEO: TV Landscape Has Never Been More Competitive

20 janv. 2026, 22:11 UTC

Acquisitions, Fusions, Rachats

Netflix Confident Warner Bros. Deal Would Pass Regulatory Review, Co-CEO Says

20 janv. 2026, 22:10 UTC

Acquisitions, Fusions, Rachats

Netflix Would Leverage Global Footprint, Streaming Expertise to Improve Warner Bros.'s HBO Max Service, Co-CEO Says

20 janv. 2026, 22:08 UTC

Acquisitions, Fusions, Rachats

Netflix Won't Raise Prices During Regulatory-Review Process for Pending Warner Bros. Deal, Co-CEO Says

20 janv. 2026, 22:07 UTC

Acquisitions, Fusions, Rachats

Netflix Sees Warner Bros. as Another Mechanism to Improve Offerings, Co-CEO Says

20 janv. 2026, 22:06 UTC

Résultats

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- Update

20 janv. 2026, 22:00 UTC

Market Talk
Acquisitions, Fusions, Rachats

ESG Roundup: Market Talk

20 janv. 2026, 21:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

Comparaison

Variation de prix

Inspire Medical Systems Inc prévision

Objectif de Prix

By TipRanks

58.69% hausse

Prévisions sur 12 Mois

Moyen 146.36 USD  58.69%

Haut 180 USD

Bas 91 USD

Basé sur 18 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

18 ratings

13

Achat

5

Maintien

0

Vente

Sentiment

By Acuity

126 / 361Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
help-icon Live chat